Michael

$BX The stock currently has a consensus rating of "Hold" and a consensus target price of $155.33.

$MRVL Recent Institutional Investor Holdings in Marvell Technology, Inc.

$MRVL Jefferies raised its price target on $MRVL from $120 to $149

$PLTR Palantir Introduction and Analysis 📈📈📈

$IDYA IDEAYA Biosciences and Servier Announce Positive Topline Results from Phase 2/3 Registrational Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA-A*02:01-Negative Metastatic Uveal Melanoma

@IndraStocks $SNDK from the way it’s trading now, could reach $900 tomorrow.

$SNDK management generating zero share holder returns for a decade before 20x'ing in a year and getting included in QQQ

$SNDK This thing just keeps squeezing form $40 to almost a $1000 in less than a year! The stock maintains its upward momentum, with a long-term outlook still pointing toward higher levels, including the $1000 area. Big watch tomorrow for day trades

$APLD Bullish 📈📈📈

$MACRO $STOXX Excess liquidity in the Eurozone banking system will fall below €2tn in 2025 and shrink by ~€3tn by 2027, returning to pre‑pandemic levels. FT

Roth Capital upgrades $TLRY to Buy TP $10. Improving beverage trends, international scaling, and a resilient Canadian market. While the stock has dipped back to mid-2025 prices, the the outlook is brighter now due to better fundamentals and a favorable regulatory environment.

$INBS Intelligent Bio Solutions (INBS) announced on Thursday the successful completion of its initial clinical study, which is needed to seek U.S. Food and Drug Administration (FDA) approval for its fingerprint-based drug testing system.

$GSAT well first leg up will be beating the 10 bil. price mark. past 79-80 per share. once that valuation gets past then maybe fun up past 100. then sky the limit-yeah

$ASTS Recently, several hedge funds and other institutional investors have adjusted their holdings in ASTS.

$ASTS Maintain bullish expectations📈📈📈

$INTC Intel and Apollo today announced a definitive agreement for Intel to repurchase the 49% equity interest in the joint venture related to Intel's Fab 34 in Ireland not held by Intel for $14.2 billion.

$UNH Raymond James upgraded to Outperform from Market Perform with tp $330. Expects expense trends to be more favorable than the market anticipates, based on recent management commentary. ing trends to outperform market expectations.

$CRML Critical Metals Reports 𝟐.𝟗𝟔% TREO, Boosts Recovery Results at Tanbreez

$GOOGL Attached is page 1 of an Oppenheimer analyst report regarding GOOGL issued yesterday.

$MSFT Attached is page 1 of a Wells Fargo analyst report regarding MSFT issued today

$GLXY New feature expands GalaxyOne's digital asset capabilities for individual investors 📈📈📈